EUVIMEDEUVIMED entdecken
Crossref

Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults

Shiwei Zhou, Samuel L Aitken

JAMA · 11.07.2023 · 330 (2) · 182

DOI: 10.1001/jama.2023.9844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 11.07.2023. Verfasst von Shiwei Zhou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Infectious Diseases, Michigan Medicine, Ann Arbor. Hauptthemen laut MEDLINE: Pneumonia, Pneumocystis, Pneumocystis carinii. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This JAMA Insights Clinical Update discusses current recommendations regarding prevention of Pneumocystis pneumonia in patients who are immunocompromised.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumonia, PneumocystisPneumocystis cariniiAdultHumansImmunocompromised HostTrimethoprim, Sulfamethoxazole Drug CombinationChemoprevention

Substanzen

Trimethoprim, Sulfamethoxazole Drug Combination

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Infectious Diseases, Michigan Medicine, Ann Arbor.
  • Department of Pharmacy, Michigan Medicine, Ann Arbor.

Zitieren

APA

Zhou, S., & Aitken, S. L. (2023). Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults. JAMA, 330(2), 182. https://doi.org/10.1001/jama.2023.9844

Vancouver

Zhou S, Aitken SL. Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults. JAMA. 2023;330(2):182. doi:10.1001/jama.2023.9844

BibTeX
@article{Zhou2023,
  author = {Zhou, Shiwei and Aitken, Samuel L},
  title = {Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults},
  journal = {JAMA},
  year = {2023},
  volume = {330},
  number = {2},
  pages = {182},
  doi = {10.1001/jama.2023.9844}
}
Kostenlos starten →